MedPath

Cognitive Behavioral Therapy(CBT) in Treatment of Methamphetamine Use Disorder

Not Applicable
Not yet recruiting
Conditions
Methamphetamine Abuse
Interventions
Behavioral: cognitive behavioral therapy
Registration Number
NCT05593796
Lead Sponsor
Assiut University
Brief Summary

The efficacy of cognitive behavioral therapy(CBT) in treatment of methamphetamine use disorder

Detailed Description

Methamphetamine (MA) use is a serious public health concern in many countries and is second to cannabis as the most widely abused illicit drug in the world.

Over the past few years; there is an alarming increase in crystal methamphetamine (Shabu) abuse in the Egyptian market and The Egyptian government is annoyed from this issue because youth within the age of productivity were targeted.

Regular methamphetamine use can be associated with a range of psychiatric symptoms, particularly psychosis, anxiety, and depression.

No FDA approved pharmacological treatments are available for Meth addiction up till now and despite great advances achieved in understanding the neurobiology of drug addiction, the therapeutic options are severely limited . Consequently, the only available treatment at present is psychosocial intervention.

The effectiveness of CBT for other substance-use disorders (e.g. alcohol-, opioid- and cocaine-use disorders) has been well documented and as such this basic treatment approach has been applied to amphetamine-type stimulant (ATS)-use disorder .

Currently, there is not enough evidence to establish the efficacy of CBT for amphetamine -type stimulant( ATS) -use disorders because of a paucity of high-quality research in this area.

The present study will examine the efficacy of Cognitive behavioral therapy in reducing methamphetamine use in comparison to medical treatment usually taken in methamphetamine use disorder

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Male
Target Recruitment
50
Inclusion Criteria
  • patients who meet the criteria for methamphetamine use disorder according to Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM 5) (10)
  • aged of 15-49 years' old
  • more than 9 year of education
  • urine drug screening positive for methamphetamine
Exclusion Criteria
  • other Axis I disorder of DSM-V criteria such as bipolar disorder, schizophrenia, depression
  • Had a legal case pending resulting in inability to commit to 12 weeks of treatment.
  • Refusal to participate
  • poly drug dependence.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Clinician-delivered CBT with tratment as usualcognitive behavioral therapy-
treatment-as-usual (TAU)cognitive behavioral therapy-
Primary Outcome Measures
NameTimeMethod
increase in the addiction severity index for methamphetamine use disorder12 weeks

0-1 No imminent problem 2-3 slight problem 4-5 moderate problem 6-7considerable difficulty

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath